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In refining methodology to develop a mouse model for inhalation of Francisella tularensis,
it was noted that both relative humidity and growth media impacted the aerosol
concentration of the live vaccine strain (LVS) of F. tularensis. A relative humidity of less
than 55% had a negative impact on the spray factor, the ratio between the concentration
of LVS in the aerosol and the nebulizer. The spray factor was significantly higher for LVS
grown in brain heart infusion (BHI) broth than LVS grown in Mueller–Hinton broth (MHb)
or Chamberlain’s chemically defined medium (CCDM). The variability between aerosol
exposures was also considerably less with BHI. LVS grown in BHI survived desiccation far
longer thanMHb-grown or CCDM-grown LVS (∼70% at 20min for BHI compared to<50%
for MHb and CCDM). Removal of the capsule by hypertonic treatment impacted the spray
factor for CCDM-grown LVS or MHb-grown LVS but not BHI-grown LVS, suggesting the
choice of culture media altered the adherence of the capsule to the cell membrane. The
choice of growth media did not impact the LD50 of LVS but the LD99 of BHI-grown LVS
was 1 log lower than that for MHb-grown LVS or CCDM-grown LVS. Splenomegaly was
prominent in mice that succumbed to MHb- and BHI-grown LVS but not CCDM-grown
LVS. Environmental factors and growth conditions should be evaluated when
developing new animal models for aerosol infection, particularly for vegetative bacterial
pathogens.
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INTRODUCTION
Tularemia is a disease found throughout North America, Europe,
and Asia that can be contracted by contact, arthropod vectors,
or inhalation (Dennis et al., 2001; Pechous et al., 2009). The
causative agent, Francisella tularensis, was first identified in 1912.
F. tularensis is a gram negative non-motile coccobacillus and is
considered a facultative intracellular bacterium. F. tularensis can
infect a significant number of mammals, arthropods, and even
fresh-water amoebae. In the environment F. tularensis has been
isolated from water, soil, and various wild animals, especially rab-
bits, hares, and rodents. In mammals the primary cell targets are
thought to be macrophages and dendritic cells. Four subspecies
have been identified: tularensis, holarctica, mediasiactica, and
novicida (Ellis et al., 2002). Subspecies tularensis strains, also des-
ignated as type A, are the most virulent and are most frequently
found in North America (type A can be further divided into A.1
and A.2) (Gurycova, 1998; Staples et al., 2006). Subspecies holarc-
tica, or type B strains, are not as virulent as type A but they can
cause human disease and are found throughout North America
and Europe.
F. tularensis was evaluated as a biological weapon and
weaponized by both the former Soviet Union and the United
States of America (the USA renounced the use of offensive
biological weapons in 1969) prior to ratification of the Biological
Weapons Convention (BWC) Treaty. In addition to being infec-
tious when inhaled, F. tularensis could be easily grown to high
titers and caused significant morbidity and mortality at very low
doses (Dennis et al., 2001). AWorld Health Organization (WHO)
report concluded that an aerosol release of 50 kg of F. tularen-
sis over a metropolitan area of 5 million would result in 250,000
casualties and 19,000 deaths (Dennis et al., 2001).
Because of the virulence and high infectivity of F. tularensis,
attenuated strains are commonly used in laboratories that lack
the specialized containment required. Subspecies novicida, which
can cause lethal disease in mice but do not typically cause dis-
ease in humans, is often used (Pechous et al., 2009). However,
novicida strains do not express a capsule which is required for
the virulence of type A and type B strains (Cox and Goldberg,
1972; Golovliov et al., 2003; Jia et al., 2010; Bandara et al., 2011).
LVS, a classically attenuated type B (holarctica) strain, is aviru-
lent in humans, rabbits, rats, and nonhuman primates (NHP) but
can cause lethal disease in mice (Lyons and Wu, 2007). Unlike
novicida strains, LVS expresses a capsule which is thought to
be similar to that of the more virulent strains. An LVS mutant
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which did not express capsule was found to be able to repli-
cate inside macrophages but was otherwise attenuated in mice
(Golovliov et al., 2003). Because of the extraordinarily low dose
of virulent F. tularensis type A required to kill mice when given
by i.n. inoculation or inhalation of small particle aerosols, it
has been argued that LVS infection of mice is a good model
of the human disease and useful for studying protective innate
and adaptive immune responses, particularly in laboratories that
are not registered for the use of select agents (Elkins et al.,
2003).
Well-characterized animal models are needed to meet the
requirements of the FDA’s Animal Rule for licensure of medi-
cal countermeasures (2002). The Animal Rule allows the use of
efficacy studies in animals to support licensure in lieu of human
efficacy. As part of meeting the requirements laid out in the
Animal Rule, additional guidance from the FDA stipulates that
the route of exposure must be the same as the anticipated route
of human exposure and that reliable quantification and repro-
ducibility of the challenge dose should be demonstrated (FDA,
2009). To achieve the goal of a standardized, reproducible system
for exposing animals, the impact of environmental factors needs
to be assessed. We report here our efforts to establish a system for
reproducibly infecting animals with F. tularensis and infect mice
with small particle aerosols containing LVS as a surrogate model
of human disease.
MATERIALS AND METHODS
BACTERIA
Frozen stocks of F. tularensis subsp. holarctica, attenuated live
vaccine strain (LVS) (graciously provided by Dr. Gerald J.
Nau, University of Pittsburgh) and subsp. tularensis strain
SCHU S4 (BEI Resources, Manassas, VA) were plated onto cys-
teine heart agar supplemented with 1% bovine hemoglobin
(CHAH; Becton-Dickinson, Franklin Lakes, NJ) and incu-
bated at 37◦C with 5% CO2 for 48 h. Isolated colonies were
resuspended in phosphate buffered saline (PBS, pH 7.2) to
obtain a bacterial suspension with optical density at 600 nm
(OD600) = 0.100 ± 0.020. Five-hundred microliters of bacterial
suspension was added to 25ml of broth culture and incu-
bated at 37◦C in vented 125ml baffled flasks with agitation at
250 RPM. Bacteria were enumerated by diluting samples 10-fold
in PBS and plating onto CHAH. Colony forming units (cfu) were
assessed between 48–96 h incubation. All work with SCHU S4
was conducted at biosafety level (BSL)-3 in the University of
Pittsburgh Regional Biocontainment Laboratory. The University
of Pittsburgh Regional Biocontainment Laboratory is a Registered
Entity with the CDC/USDA for work with F. tularensis.
BROTHMEDIA
Three different broth media were evaluated in these studies:
(1) modified Mueller–Hinton medium (MHb) supplemented
with 1.23mM calcium chloride dihydrate, 1.03mM magnesium
chloride hexahydrate, 0.1% (wt/vol) glucose, 0.025% (wt/vol)
ferric pyrophosphate, and 2% (vol/vol) IsoVitaleX (Becton-
Dickinson, Franklin Lakes, NJ); (2) Chamberlain’s chemically
defined medium (CCDM) (Chamberlain, 1965); or (3) brain
heart infusion (BHI) broth (Becton-Dickinson, Franklin Lakes,
NJ). MHb was prepared and sterilized by autoclaving in accor-
dance with manufacturer’s instructions. BHI and CCDM were
sterilized by membrane filtration after pH was confirmed.
MICE
Eight to ten week old female Balb/c mice (Charles River, MA)
were provided with food and water ad libitum and housed in
bio-containment caging (Allentown Inc, Allentown, NJ). All ani-
mal work was performed according to Institutional Animal Care
and Use Committee (IACUC) guidelines of The University of
Pittsburgh.
CLINICAL SCORING AND EUTHANASIA
Mice were weighed daily and monitored at least twice daily for
changes appearance and behavior; mice that were determined to
be moribund (either by score or greater than 20% weight loss)
were humanely euthanized promptly by carbon dioxide intox-
ication and necropsied after death was confirmed. Scoring was
given as a combined score of natural behavior, provoked behav-
ior, and appearance. Natural behavior: normal = 1; less peer
interaction = 2; little peer interaction, less mobile = 3; no peer
interaction, vocalization, restless or still = 4; Provoked behav-
ior: normal = 1; subdued but normal when stimulated = 2;
subdued even when stimulated = 3; unresponsive even when
stimulated = 4; Appearance: normal= 1; reduced grooming = 2;
dull/rough coat or ocular/mucosal discharge = 3; hunched, pilo-
erection = 4.
AEROSOL EXPOSURES
Aerosols of LVS cultures were generated using 3-jet Collison neb-
ulizers (BGI, Inc. Waltham, MA) that create a monodisperse
aerosol approximately 1–2µm in size controlled by the AeroMP
bioaerosol exposure system (Biaera Technologies, Hagerstown,
MD). Mice were exposed inside either whole-body (Biaera
Technologies) or nose-only (CH Technologies, Westwood, NJ)
rodent exposure chambers. Aerosol sampling was performed
using all-glass impingers (AGI-30; Ace Glass, Vineland, NJ) con-
taining 10ml of culture media and 0.08% Antifoam A (Sigma-
Aldrich, St. Louis, MO). Nebulizer and AGI contents were diluted
10-fold in PBS and plated onto CHAH plates to quantify recov-
ered bacteria. Aerosol concentration was determined as the prod-
uct of the AGI concentration and the volume of liquid in the
AGI divided by the product of the AGI flow rate (6 l/min) and
duration of the aerosol (Roy and Pitt, 2005). Spray factor (SF)
was calculated as the aerosol concentration divided by the nebu-
lizer concentration. Respiratory minute volume was determined
using Guyton’s formula (Guyton, 1947). Presented dose was
measured as the product of the minute volume by the aerosol
concentration and the duration of the aerosol (Roy and Pitt,
2005).
CAPSULE REMOVAL
Adapted from (Hood, 1977), F. tularensis LVS was grown in
CCDM, MHb, or BHI to pre-stationary phase, resuspended in
0.8 or 10% NaCl solution (pH 6.4–6.8) and stored 4 days at 4◦C.
Bacteria were centrifuged 2000g × 30min and cell pellets were
resuspended in respective media prior to aerosolization.
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DESICCATION ASSAY
F. tularensis LVS was grown in CCDM, MHb, or BHI to
pre-stationary phase, washed with PBS and resuspended in
PBS. Sterile cellulose nitrate gridded filter papers (Whatman,
Piscataway, NJ) were placed in sterile petri dishes and 100–300
cfus of washed F. tularensis were instilled onto each paper. At the
reported time intervals from 0 to 60min postinstillation, papers
were placed inoculated side up onto CHAH plates and incubated
at 37◦C with 5% CO2 for 48–96 h. Percent survival was calculated
against non-desiccated LVS inoculums.
TISSUE COLONIZATION
Lung, liver, and spleen organs were removed from moribund
and euthanized mice, weighed and frozen at −80◦C. Thawed
organs were homogenized in PBS with an Omni TH homogenizer
with disposable plastic soft tissue probes (Omni International,
Kennesaw, GA), filtered through a 0.75 micron mesh (Fisher
Scientific), diluted 10-fold in PBS and plated on CHAH plates
for enumeration of bacterial load. The quantity of bacteria per
sample was calculated as cfu per gram of tissue.
STATISTICS
Significance tests were performed with Graph Pad Prism Software
(GraphPad, La Holla, CA) using unpaired Student’s t-tests and
One-Way ANOVA. Probit slope analysis of survival curves was
used to determine the LD50 using NCSS 2004 software (Number
Cruncher Statistical Systems, Kaysville, Utah).
RESULTS
As part of initial efforts to develop a mouse model for pneu-
monic tularemia, aerosols were conducted without animals to
define factors important for achieving consistent, reproducible
dosing. Spray factor is the ratio of the aerosol concentration
to the nebulizer concentration; it can be used as both a means
to determine the nebulizer concentration needed to achieve a
desired presented dose and the performance of an aerosol rel-
ative to other aerosols of the same agent (Roy and Pitt, 2005).
The higher the spray factor, the lower the concentration needed in
the nebulizer to achieve a desired presented dose. Initial aerosols
to determine the spray factor of F. tularensis were conducted
using LVS grown in Mueller–Hinton broth (MHb) overnight at
37◦C in a shaker after a two day culture at 37◦C, 5% CO2 on
CHAH. As shown in Figure 1A, when using a 3-jet Collison neb-
ulizer the spray factor for LVS was significantly higher with a
nose-only exposure chamber than with a whole-body exposure
chamber (5.4 × 10−8 vs. 1.3 × 10−8, respectively; p = 0.0087).
Using the nose-only chamber, the spray factor for 1-jet Collison
(1.4 × 10−9) was considerably lower than had been found with
the 3-jet Collison (Figure 1B); the difference was statistically
significant (p = 0.0023).
Prior reports have shown that for vegetative bacteria in general
and for F. tularensis specifically, relative humidity levels inside the
exposure chamber can impact the aerosol concentration, thereby
changing the spray factor (Cox and Goldberg, 1972). The Biaera
AeroMP control system monitors temperature, humidity, and
pressure in the exposure chamber throughout each exposure and
saves that information in a log file. Figure 2A shows the relative
FIGURE 1 | Spray factor of LVS with different exposure chambers and
nebulizers. F. tularensis strain LVS was grown in MHb overnight and then
aerosolized into a whole-body or nose-only exposure chamber (A) or with a
Collison nebulizer using a 1- or 3-jet nozzle into a nose-only exposure
chamber (B). Aerosol samples were collected in an AGI and plated to
determine aerosol concentration of LVS. Plots show the spray factor (ratio
of aerosol concentration to nebulizer concentration) for individual aerosol
exposures (circles and squares) and the median (line) value.
humidity recorded for the nose-only and whole-body chambers
using either 1-jet or 3-jet Collison nebulizers. Although they all
roughly started at about the same level, considerably higher rela-
tive humidity was achieved with the 3-jet nebulizer, particularly in
the nose-only exposure chamber. A humidification chamber was
used to compare the spray factor for LVS using a 3-jet Collison
nebulizer in a whole-body chamber. Increasing the average rela-
tive humidity to 72% led to a 2-log increase in spray factor over
unmodified chamber air which had a average relative humidity of
48% (Figure 2B). The difference in spray factor (5.1 × 10−8 vs.
6.6 × 10−10 for 72 and 48% RH, respectively) was statistically sig-
nificant (p = 0.01). A series of aerosols conducted at different RH
found a dramatic improvement in spray factor between 50–60%
RH for LVS (Figure 2C).
Another potential factor in aerosolization of F. tularensis was
the growth media used. The method adopted was modified from
a colleague at USAMRIID, Dave Waag, which itself was a modi-
fied protocol from that used to grow and prepare Yersinia pestis
for aerosolization (Davis et al., 1996). Initial aerosols had used
LVS grown in MHb; however, a review of the literature identi-
fied CCDM and BHI as other liquid media that could be used
to culture of LVS (Chamberlain, 1965; Hazlett et al., 2008). LVS
was grown in all three culture media and samples were taken at
a number of points to read the OD600 and determine bacterial
concentration (Figure 3). Although the OD600 values obtained
at given timepoints were different between the three culture
media, regression analysis indicates that the time at which the
peak of the curve occurred was approximately the same. For
aerosolization experiments, 18 h was chosen for all three cul-
ture conditions as this corresponded with late-log/pre-stationary
phase growth.
LVS was then grown in all three culture conditions using
the established protocol (2 days on CHAH agar; 18 h in broth
media, shaking at 37◦C), harvested, and aerosolized over a range
of nebulizer concentrations. Fresh culture media of the same
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FIGURE 2 | Effect of relative humidity on aerosolization of LVS. Relative
humidity during exposures is monitored and logged by the AeroMP system.
In (A), the graph shows the change in relative humidity over time using
different nebulizer/exposure chamber combinations without using the
humidification loop to artificially increase humidity. In (B), the graph shows
spray factors for individual exposures (squares and triangles) with the
median and standard deviations at two different relative humidity levels. In
(C) the graph shows the spray factors for a number of runs at a range of
relative humidity values. Data in (C) were analyzed in Prism using
four-parameter logistic regression.
FIGURE 3 | Growth of LVS in different liquid broth media. LVS was
cultured for 2 days on CHAH prior to being cultured overnight in (A) MHb,
(B) CCDM, and (C) BHI liquid culture media. Graphs show the change in
optical density at 600nm at different times after the culture was started
(circles). Boltzmann sigmoidal semi-logistic regression was used to fit the
line shown on each graph.
type used to grow LVS was used for collection of aerosol sam-
ples. Relative humidity was kept high (75%) to ensure differ-
ences in humidity did not alter the spray factor. The results are
shown in Figure 4A. LVS grown in BHI gave the best overall
spray factor (2.9 × 10−7) while MHb was approximately 1 log
lower (3.6 × 10−8) and CCDM-grown LVS was the lowest (4.7 ×
10−9). Using a One-Way ANOVA, the spray factor for BHI was
significantly better than that obtained for both MHb and CCDM
(p < 0.05); the spray factor for MHb was not, however, sig-
nificantly different from CCDM. The coefficient of variation
for BHI (0.56) was also lower than that obtained for either
MHb (0.85) or CCDM (1.15). The effects of culture broth
on spray factor were not exclusive to LVS; similar data were
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FIGURE 4 | Impact of growth media on aerosolization of F. tularensis.
Graphs show spray factor for F. tularensis after growth in different liquid
culture media. (A) Shows the spray factor for individual aerosol exposures
of LVS grown in MHb (circles), CCDM (squares), and BHI (triangles) along
with the mean and standard deviation for each growth condition. Lines with
(*) are statistically significant based on two-tailed Student’s t-test. (B) Spray
factors for individual aerosol exposures of LVS or SCHU S4 grown in CCDM
or BHI along with mean and standard deviation for each growth condition.
obtained with a virulent type A strain, SCHU S4 (Figure 4B).
Differences in spray factor between LVS and SCHU S4 have
been reported (Brasel et al., 2009) but using our methods for
culturing and aerosolizing F. tularensis no significant difference
in spray factor was seen between LVS or SCHU S4 in either
CCDM or BHI.
In a prior report establishing the importance of RH in
aerosolization of F. tularensis, it was found that removing the
capsule that protects the bacterium rendered it susceptible to
FIGURE 5 | Growth media impact on LVS desiccation survival time.
Graph in (A) shows impact of liquid broth culture on survival time of LVS
from desiccation on Whatman filter paper. Data shown is mean values for
two experiments with the standard deviation. Graph in (B) shows spray
factor for individual aerosol exposures and means of LVS cultures that were
washed and incubated for 3 days in fresh media, 0.8 or 10% saline.
increased salt concentration (Hood, 1977). The spray factors
obtained from aerosolization of LVS grown in the three culture
broths suggested that capsule production was different between
the three culture broths and could explain the aerosol results.
To evaluate whether this was the case, LVS was grown in each
broth condition overnight and evaluated for how long it could
survive desiccation on Whatman filter paper (Figure 5A). At 10
and 20min after placement on the filter paper, survival was bet-
ter for BHI-grown LVS than for CCDM or MHb grown LVS.
Only at 10min was this difference statistically significant and
only in comparison to CCDM (p = 0.006). Regardless of culture
condition, LVS did not survive at 40min of desiccation.
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Another possible explanation for the aerosol data was that cul-
turing in the different broth media induced differences in the
anchoring of the capsule to the cell membrane of F. tularensis.
Incubation in 10% saline for 3 days at 4◦C has been shown to be
sufficient to remove the capsule from F. tularensis, thereby ren-
dering the bacterium avirulent in guinea pigs (Hood, 1977). LVS
grown in the three culture broths was washed twice to remove
any remaining broth and incubated for three days at 4◦C in
either 10% saline, physiological saline (0.85%), or in fresh culture
media. Following the 3 days treatment, each was washed twice,
resuspended in fresh culture media, and aerosolized. The spray
factors resulting from that experiment are shown in Figure 5B.
As expected, incubation of CCDM or MHb grown LVS in saline
resulted in a considerable decrease in spray factor. Capsule was
most easily stripped from CCDM-grown LVS as illustrated by the
difference in spray factor at 0.85% saline, which was the same
as incubation at 10% saline. LVS grown in MHb appeared more
resistant, with an intermediate loss in spray factor at 0.85% saline
although the overall decline in spray factor at 10% saline com-
pared to fresh media was higher (3 log10 vs. 2 log10 for MHb
and CCDM, respectively). The spray factor for both was virtu-
ally identical after incubation in 10% saline, suggesting that at
this concentration of saline the capsule was completely removed
and offered no protection against saline in the aerosol. BHI
grown LVS, in contrast, was completely resistant to stripping of
the capsule; at either 0.85 or 10% saline there was no differ-
ence in the spray factor compared to incubation in fresh culture
media.
Balb/c mice were exposed to small particle aerosols con-
taining LVS at a range of doses to evaluate the virulence of
aerosolized F. tularensis grown in the different culture condi-
tions (Figure 6). Mice were not allowed to proceed to death
but were euthanized when they met either a series of clini-
cal signs indicative of a moribund state or greater than 20%
weight loss. Regardless of dose, mice were found to be mori-
bund between 5–6 days after exposure. At lower doses, there was
little difference in survival between the different culture condi-
tions but at higher doses there was the suggestion that BHI-grown
LVS might be more virulent. Probit analysis confirmed that the
LD50 was virtually identical between the three culture condi-
tions and that the time of death was also essentially the same
(Table 1). The probit analysis also indicated that the LD99, the
dose at which one would expect the death of all unprotected
mice, was almost a half-log10 lower with BHI than with either
CCDM or MHb.
Mice were also weighed daily to assess illness by weight loss
(Figure 7). Regardless of culture condition, little change in weight
was seen at the lowest challenge doses where all mice survived. At
higher doses, weight loss was first notable on either day 3 or 4 after
exposure and declined dramatically through day 6. Linear regres-
sion analysis indicated that at the highest doses, mice infected
with LVS grown inMHb or CCDM lost weight at a faster rate than
did mice infected with LVS grown in BHI although the weight
loss rate was also dose dependent and did not predict survival. As
shown in Figure 7D, mice that survived exposure at a high dose
of MHb grown LVS lost weight at a rate equivalent to that of mice
that succumbed in the same group.
FIGURE 6 | Survival of mice after aerosol exposure to LVS grown in
different culture media.Mice were exposed to aerosols containing LVS
grown in (A) MHb, (B) CCDM, and (C) BHI at a range of doses sufficient for
determining the median lethal dose (n = 10 mice per dose). Graphs are
Kaplan–Meier plots with doses shown in lower left.
In addition to weight loss, mice were scored for changes
in behavior and appearance (Figure 8). Clinical signs noted
included dull coat, piloerection, hunching, rapid breathing, less
peer interaction, and response to gentle prodding. Regardless of
culture condition, at higher doses the onset of clinical signs coin-
cided or slightly preceded detectable weight loss. Clinical signs
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Table 1 | Impact of culture media on virulence of LVS.
MHb CCDM BHI
LD50 (cfu) 1210 950 1280
LD99 (cfu) 1.5 × 105 1.2 × 105 4.4 × 104
MTD* 5.2 5.8 5.5
*Mean time to death.
were noted in mice that survived infection, including those that
demonstrated little if any weight loss. There were differences in
the onset and severity of clinical signs noted in mice that survived
infection with LVS grown in different culture broth, with both
earlier onset and greater severity after infection with LVS grown
in BHI (see clinical scores for the mice infected with lower doses
in Figure 8).
Mice that succumbed to LVS were necropsied after euthanasia.
Lungs and spleens were weighed and bacterial load was assessed
in lung, liver, and spleen (Figure 9). The ratio of lung weight
to body weight after infection with LVS was roughly equiva-
lent for all three culture conditions to that of the lungs from
normal mice. However, only for BHI-grown LVS was the dif-
ference significant from naïve mice (p = 0.03). For the spleen,
the organ/body weight ratio was higher than normal from mice
infected with LVS grown in MHb or BHI (p < 0.001). In mice
infected with LVS grown in CCDM, there was no difference
in spleen weight relative to controls. LVS titers in each of the
organs examined were far more variable in mice infected with
MHb-grown LVS than either CCDM- or BHI-grown LVS. LVS
titers were highest in the lung and levels were roughly equiva-
lent across all three culture conditions. In the liver, LVS titers
were a log higher for MHb and CCDM grown LVS than BHI
grown LVS, although the difference was only significant when
comparing BHI and CCDM (p = 0.009). In the spleen, the con-
centration of LVS was a log higher in the spleens of mice infected
with CCDM grown LVS than either MHb or BHI, although the
difference was again only significant with the BHI-grown LVS
(p = 0.0005).
FIGURE 7 | Weight loss in mice after aerosol exposure to LVS grown in
different culture media.Mice were weighed daily beginning the day of
exposure and continuing through day 10 after infection. Mice were exposed
to aerosols containing LVS grown in (A,D) MHb, (B) CCDM, and (C) BHI at a
range of doses (n = 10 per dose). Graphs (A–C) show average daily weight
lost from baseline (day 0) for each group; error bars show standard deviation;
graph (D) shows individual weights for mice in second highest dose group
(3982 cfu) exposed to LVS grown in MHb.
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FIGURE 8 | Clinical scoring of disease in mice after aerosol exposure to
LVS grown in different culture media.Mice were scored daily beginning
the day of exposure and continuing through day 10 after infection for
changes in behavior and appearance. Mice were exposed to aerosols
containing LVS grown in (A) MHb, (B) CCDM, and (C) BHI at a range of
doses (n = 10 per dose). Graphs show average daily score for each group;
error bars show standard deviation.
FIGURE 9 | Bacterial load in tissues of mice after aerosol exposure to
LVS grown in different culture media.Mice became moribund after LVS
infection were euthanized and necropsied. The liver, lung, and spleen were
removed, weighed, and then analyzed to determine the bacterial titer in
each tissue. Graphs in (A,B) show weight for lungs (A) and spleens (B) at
time of necropsy from individual mice infected with LVS grown in MHb,
CCDM, or BHI as well as the mean for each group and standard deviation.
Weights of tissues from naive, uninfected mice are also shown. Graph in
(C) shows a box and whiskers plot for the bacterial titer from the lung, liver,
and spleen of mice that succumbed to infection with LVS grown in MHb
(white boxes), CCDM (light gray boxes), or BHI (dark gray boxes).
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DISCUSSION
Tomeet the requirements of the FDA’s Animal Rule requires care-
ful characterization and standardization of experimental aerosols
with the pathogen of interest to achieve reproducible infection
at desired challenge doses. A survey of the published literature
and discussions with other laboratories performing research on
F. tularensis, revealed that a variety of methods were used to
culture and aerosolize F. tularensis. Some laboratories aerosolize
freshly thawed cultures while others grow in liquid broth directly
from frozen stocks or first on agar plates followed by culture
in liquid broth. Most laboratories utilize MHb for growth and
aerosolization of F. tularensis although some use CCDM. BHI
broth has also been reported to support the growth of F. tularen-
sis. In our initial efforts reported here we utilized the LVS strain
to infect mice, demonstrating that relative humidity and cul-
ture media altered the aerosolization but not the virulence of
F. tularensis.
Other efforts to evaluate the impact of culture media on
F. tularensis virulence have been mixed. CCDM was found to
enhance virulence of LVS in mice, but only after repeated passage
in CCDM in culture which appeared to enhance capsule pro-
duction (Cherwonogrodzky et al., 1994). In our system, culture
in CCDM overnight did not enhance the virulence of LVS, sug-
gesting that some switch/mutation occurred during the multiple
passages reported in the prior study that triggered the increased
capsule production and virulence. Similar to what was reported
by Hazlett et al. for BHI and MHb, we saw no difference in the
LD50 or time to death between all three culture media (Hazlett
et al., 2008). Probit analysis suggests that culturing overnight
in BHI did lower the LD99, but the number of animals used is
not sufficient to establish whether this difference is significant.
It is possible that had we used death as an endpoint that some
mice that were euthanized might have survived, thereby changing
the results of the LD50/99 determination. The differences noted
between culture conditions in the size of the spleen and bacterial
titers in the liver and spleen would support this notion. Evaluation
of the clinical signs recorded, however, could argue the opposite
as a number of mice that developed clinical signs indicative of
severe disease (>10% weight loss, ruffled fur, reduced response to
stimuli) did survive.
Our data suggest that there may be a difference in how well
the capsule is anchored to the cell membrane based on culture
conditions. Hazlett et al. have also reported that BHI-grown LVS
behaves more like LVS freshly isolated from macrophages, with
a similar mRNA profile. One could hypothesize that perhaps
outside of a host cell, F. tularensis does not anchor the cap-
sule well to the cell membrane in order to promote shedding
of the capsule as a means of immune evasion. Once engulfed
by a macrophage, this shedding process might then be deleteri-
ous, forcing the bacterium to better anchor the capsule to the
membrane. This may have potential implications for the ability
of vaccines to protect against F. tularensis infection and requires
further study.
The observation that spray factor was not only improved but
more consistent when using BHI broth was somewhat surpris-
ing. It is possible that the fat content, primarily brain lipids, of
the broth prevented dehydration of the particle. Data from the
desiccation and capsule stripping experiments support the notion
that changes in gene expression resulting from culturing in BHI
anchored the capsule to the membrane better. The improved
anchoring of the capsule would increase resistance to rising salt
concentrations in the aerosol particle as the particle reduces in
size and desiccates while traveling into the exposure chamber.
Results with SCHU S4 were virtually identical indicating that the
differences in spray factor were not an LVS or F. tularensis type
B-only phenomenon.
There is of course concern that reporting the results of exper-
iments such as these might represent “dual-use research” that
could be used for nefarious purposes or by terrorists to improve
efforts to develop and disseminate biological weapons. In the
U.S. government’s recently issued policy on dual-use research, it
lists specific categories of experiments to consider for potential
“dual-use”, including any experiment that “Increases the stabil-
ity, transmissibility, or the ability to disseminate the agent or
toxin” [REF]. Evaluating culture media for the effect on aerosol
spray factor could be seen as falling into that category. However,
these conclusions cannot be made from this report because spray
factor does not assess survival of pathogens in an aerosol and
in this case was limited to short duration (10min) experiments
under highly controlled settings in a dynamic chamber. The con-
trolled conditions (e.g., temperature, humidity, light, and air flow
rate) achieved in controlled animal exposure chambers are not
comparable or reproducible to open systems such as those that
pose a bioterrorism concern. Thus, these laboratory-based find-
ings are not directly applicable to intentional dissemination of
F. tularensis to cause harm. Finally, if these results are not pub-
lished in the open, peer-reviewed literature then it would be
hard to meet the FDA’s goal of highly characterized, standardized
and reproducible aerosol exposures to meet the requirements of
the Animal Rule for license of medical countermeasures against
F. tularensis.
We report here efforts to establish a standardized method for
reproducibly infected animals with aerosols containing F. tularen-
sis. The results are in line with prior reports regarding the need to
have high relative humidity. Culture media impacted spray fac-
tor but did not alter virulence of LVS in mice. Further research
is needed to understand the mechanism(s) underlying the differ-
ences observed in spray factor resulting from the choice of culture
media.
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